Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
A few weeks after my breakdown in the doctors office, I spoke with my physician about the possibility of starting a GLP-1
Regulatory Toxicology and Pharmacology (2020) 12
10.2147/OTT.S227915 68 HershmanJ
In contrast, GLP-1R agonists are safer, and several studies have shown that GLP-1R agonists significantly improve cognitive impairment ( Figure 1 ) (25, 26, 8385)
While the current body of evidence has predominantly focused on fat versus lean mass, relatively few studies (mostly subgroup analyses) have examined SMI, ASMI, and physical performance